Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
83.456,71
-3,14%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ImmunityBio Inc (IBRX) ImmunityBio Inc (IBRX) Notizie

ImmunityBio Inc

IBRX
3,04
0,05 (1,67%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/3/202513:47EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
03/3/202513:42EDGAR2Form 8-K - Current report
03/3/202513:30BWImmunityBio Reports Sales Momentum & Unit Growth Since..
28/2/202501:10BWImmunityBio Receives FDA RMAT Designation for ANKTIVA® and..
26/2/202503:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202503:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202503:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202515:00BWFDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG)..
13/2/202521:05BWImmunityBio Announces UK Medicines and Healthcare Products..
13/2/202502:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202522:52EDGAR2Form 8-K - Current report
29/1/202514:30BWImmunityBio Announces Collaboration with BeiGene on..
27/1/202515:00BWImmunityBio Announces European Medicines Agency Acceptance..
25/1/202502:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202523:20BWImmunityBio Provides Regulatory Update on Anticipated FDA..
06/1/202515:00BWImmunityBio Announces Permanent J-code (J9028) for ANKTIVA®..
03/1/202522:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202414:00GLOBED. Boral Capital Served as Co-Manager to ImmunityBio, Inc...
12/12/202412:45EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/12/202413:46EDGAR2Form 8-K - Current report
11/12/202413:30BWImmunityBio, Inc. Announces Pricing of Public Offering of..
10/12/202423:28EDGAR2Form 8-K - Current report
10/12/202423:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/12/202422:24BWImmunityBio, Inc. Announces Proposed Public Offering of..
21/11/202416:00PRNUSImmunityBio and nCartes Enter Collaboration Agreement on..
19/11/202415:00PRNUSImmunityBio, Inc. Investor Alert (NASDAQ: IBRX): Schubert..
19/11/202414:01EDGAR2Form 8-K - Current report
19/11/202414:00BWImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of..
12/11/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:15BWImmunityBio Reports Third-Quarter 2024 Financial Results
24/10/202415:00BWFirst Patients Dosed in Phase 1 Clinical Study of..
21/10/202415:00BWImmunityBio to Participate in the Jefferies London..
09/9/202414:30BWImmunityBio Presents Positive Long-Term Overall Survival..
12/8/202414:46BWImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen..
12/8/202414:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202415:00BWImmunityBio Announces Study of ANKTIVA® in Combination with..
25/7/202417:02PRNUSKuehn Law Encourages Investors of ImmunityBio, Inc. to..
18/7/202403:48EDGAR2Form 8-K - Current report
20/6/202415:00BWImmunityBio Announces Insurance Coverage of ANKTIVA® Across..
14/6/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:36EDGAR2Form 8-K - Current report
07/6/202415:13BWImmunityBio Announces 2024 Annual Meeting of Stockholders..
17/5/202415:00BWConnecting the Dots of ANKTIVA’s Triangle Offense: A Deep..
09/5/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:00BWImmunityBio Completes GMP Drug Substance Manufacturing..
Apertura: 2,95 Min: 2,9111 Max: 3,065
Chiusura: 2,99

La tua Cronologia

NASDAQ
IBRX
ImmunityBio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci